Live feed07:30:00·6mPRReleasevia QuantisnowDyne Therapeutics Announces U.S. FDA Acceptance of Biologics License Application (BLA) for Z-Rostudirsen in Exon 51 Duchenne Muscular Dystrophy (DMD)ByQuantisnow·Wall Street's wire, on your screen.DYN· Dyne Therapeutics Inc.Health Care
